Entera Bio Ltd.

US$3.14As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ENTXHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (7.99%)
Div yield —
ROE (20.33%)
Biotechnology
Beta (5Y) 1.46
PE TTM —
TSR TTM 7.90%
Mkt cap US$546.1M
ROIC (7.93%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.56
13.49%
(68.31%)
Hold 0|8|2|2|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.05
0.05
7.10%
11.92%
12.63%
10.40%
Revenue$M
39.05
39.35
41.40
41.17
5.66%
7.83%
11.09%
11.23%
Peers (US$546.1M)
Cap (US$)
PE
203.6M
—
542.4M
—
Capital
TTM
5Y
10Y
Leveragex
2.447
0.175
0.146
EBIT/Intx
1.328
0.517
0.514
Own earn%
206.16
50.48
75.28
Sh yield%
20.63
17.81
17.41
Owners
Insiders/Inst%
1.65
74.45
Short interest%
1.62
SBC / revenue%
5.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
1–16
$1 testx
0.0
Incr. ROIC%
19